Pay in 4 interest-free payments of $7.34 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Research Applications In laboratory research, AMINO-1MQ is investigated for NNMT enzyme inhibition and its downstream effects on NAD+ and S-adenosylmethionine (SAM) metabolism, adipocyte lipogenesis, and energy-expenditure pathways
The morning dose captures the primary lipolytic window while the evening dose extends the fat-burning signal
The vial format supports precise dose-response studies in cell-culture and animal models of NNMT inhibition and adipose-tissue metabolic regulation
Why people explore AOD 9604/MOTS-C AOD 9604 drives lipolysis to break down existing fat stores
Research protocols using 5-Amino-1MQ typically administer 50100mg daily via subcutaneous injection, based on human equivalent dose scaling from rodent studies where 10mg/kg bodyweight produced measurable NNMT suppression and increased NAD+ bioavailability
Enhanced fat metabolism The primary benefit of 5-amino-1mq is its effect on fat metabolism
